MedTrace Logo

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

NCT00697450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2016-11-23

No results posted yet for this study

Summary

This study is conducted in Europe. Observational study evaluating the body weight progress during the treatment with insulin detemir (Levemir®) in Type 2 patients, previously treated with other basal insulins

Conditions

Interventions

DRUG

insulin detemir

Start dose, frequency of dosing, dose titration to be prescribed by the physician as a result of a normal clinical evaluation

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00697450 on ClinicalTrials.gov